Wellington Management Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.89B | Sell |
13,537,991
-2,369,313
| -15% | -$332M | 0.35% | 62 |
|
|
2025
Q4 | $1.95B | Sell |
15,907,304
-9,711,230
| -38% | -$1.18B | 0.34% | 66 |
|
|
2025
Q3 | $2.84B | Sell |
25,618,534
-11,911,976
| -32% | -$1.35B | 0.5% | 38 |
|
|
2025
Q2 | $4.16B | Buy |
37,530,510
+10,171,543
| +37% | +$1.08B | 0.76% | 17 |
|
|
2025
Q1 | $3.07B | Sell |
27,358,967
-8,300,040
| -23% | -$856M | 0.59% | 40 |
|
|
2024
Q4 | $3.29B | Buy |
35,659,007
+1,058,331
| +3% | +$95.3M | 0.6% | 29 |
|
|
2024
Q3 | $2.9B | Buy |
34,600,676
+11,665,593
| +51% | +$890M | 0.51% | 44 |
|
|
2024
Q2 | $1.57B | Buy |
22,935,083
+2,367,331
| +12% | +$158M | 0.28% | 84 |
|
|
2024
Q1 | $1.51B | Buy |
20,567,752
+1,937,618
| +10% | +$149M | 0.27% | 97 |
|
|
2023
Q4 | $1.51B | Buy |
18,630,134
+2,350,550
| +14% | +$183M | 0.28% | 86 |
|
|
2023
Q3 | $1.22B | Sell |
16,279,584
-361,918
| -2% | -$27.8M | 0.24% | 104 |
|
|
2023
Q2 | $1.28B | Buy |
16,641,502
+12,539,306
| +306% | +$1B | 0.24% | 102 |
|
|
2023
Q1 | $340M | Buy |
4,102,196
+1,102,961
| +37% | +$91.4M | 0.07% | 270 |
|
|
2022
Q4 | $257M | Buy |
2,999,235
+2,703,726
| +915% | +$214M | 0.05% | 333 |
|
|
2022
Q3 | $18.2M | Sell |
295,509
-32,650
| -10% | -$2.06M | ﹤0.01% | 935 |
|
|
2022
Q2 | $20.3M | Sell |
328,159
-401,336
| -55% | -$24.8M | ﹤0.01% | 940 |
|
|
2022
Q1 | $43.4M | Buy |
729,495
+23,391
| +3% | +$1.5M | 0.01% | 799 |
|
|
2021
Q4 | $51.3M | Buy |
706,104
+415,317
| +143% | +$28.6M | 0.01% | 813 |
|
|
2021
Q3 | $20.3M | Sell |
290,787
-13,251
| -4% | -$931K | ﹤0.01% | 1083 |
|
|
2021
Q2 | $20.9M | Sell |
304,038
-212,419
| -41% | -$14.2M | ﹤0.01% | 1086 |
|
|
2021
Q1 | $33.4M | Sell |
516,457
-222,136
| -30% | -$14.3M | 0.01% | 928 |
|
|
2020
Q4 | $43M | Sell |
738,593
-65,816
| -8% | -$3.97M | 0.01% | 809 |
|
|
2020
Q3 | $50.8M | Sell |
804,409
-143,824
| -15% | -$9.97M | 0.01% | 692 |
|
|
2020
Q2 | $73M | Sell |
948,233
-1,205,686
| -56% | -$92.4M | 0.02% | 592 |
|
|
2020
Q1 | $161M | Sell |
2,153,919
-2,070,421
| -49% | -$143M | 0.04% | 350 |
|
|
2019
Q4 | $274M | Buy |
4,224,340
+2,789,853
| +194% | +$182M | 0.06% | 317 |
|
|
2019
Q3 | $90.9M | Buy |
1,434,487
+182,850
| +15% | +$12M | 0.02% | 568 |
|
|
2019
Q2 | $84.6M | Buy |
1,251,637
+66,217
| +6% | +$4.36M | 0.02% | 610 |
|
|
2019
Q1 | $77.1M | Sell |
1,185,420
-974,572
| -45% | -$64.8M | 0.02% | 612 |
|
|
2018
Q4 | $135M | Sell |
2,159,992
-294,144
| -12% | -$20.6M | 0.03% | 425 |
|
|
2018
Q3 | $189M | Buy |
2,454,136
+913,704
| +59% | +$69M | 0.04% | 401 |
|
|
2018
Q2 | $109M | Sell |
1,540,432
-365,368
| -19% | -$25.8M | 0.02% | 555 |
|
|
2018
Q1 | $144M | Buy |
1,905,800
+111,918
| +6% | +$8.9M | 0.03% | 457 |
|
|
2017
Q4 | $129M | Buy |
1,793,882
+256,147
| +17% | +$19.5M | 0.03% | 480 |
|
|
2017
Q3 | $125M | Sell |
1,537,735
-123,826
| -7% | -$9.47M | 0.03% | 483 |
|
|
2017
Q2 | $118M | Buy |
1,661,561
+20,552
| +1% | +$1.37M | 0.03% | 459 |
|
|
2017
Q1 | $111M | Sell |
1,641,009
-213,960
| -12% | -$15M | 0.03% | 472 |
|
|
2016
Q4 | $133M | Sell |
1,854,969
-408,850
| -18% | -$30.4M | 0.03% | 412 |
|
|
2016
Q3 | $179M | Sell |
2,263,819
-2,198,951
| -49% | -$179M | 0.04% | 347 |
|
|
2016
Q2 | $372M | Sell |
4,462,770
-2,452,084
| -35% | -$218M | 0.1% | 207 |
|
|
2016
Q1 | $635M | Sell |
6,914,854
-6,018,365
| -47% | -$543M | 0.17% | 135 |
|
|
2015
Q4 | $1.31B | Sell |
12,933,219
-1,099,000
| -8% | -$114M | 0.34% | 73 |
|
|
2015
Q3 | $1.38B | Sell |
14,032,219
-961,744
| -6% | -$107M | 0.38% | 66 |
|
|
2015
Q2 | $1.76B | Sell |
14,993,963
-1,576,697
| -10% | -$172M | 0.45% | 51 |
|
|
2015
Q1 | $1.63B | Buy |
16,570,660
+1,972,252
| +14% | +$200M | 0.42% | 54 |
|
|
2014
Q4 | $1.38B | Sell |
14,598,408
-3,995,309
| -21% | -$413M | 0.36% | 61 |
|
|
2014
Q3 | $1.98B | Sell |
18,593,717
-3,797,171
| -17% | -$372M | 0.55% | 36 |
|
|
2014
Q2 | $1.86B | Sell |
22,390,888
-7,935,014
| -26% | -$618M | 0.5% | 44 |
|
|
2014
Q1 | $2.15B | Sell |
30,325,902
-4,785,208
| -14% | -$375M | 0.6% | 32 |
|
|
2013
Q4 | $2.64B | Sell |
35,111,110
-2,526,817
| -7% | -$176M | 0.76% | 19 |
|
|
2013
Q3 | $2.37B | Sell |
37,637,927
-807,222
| -2% | -$48.2M | 0.74% | 20 |
|
|
2013
Q2 | $1.97B | Buy |
+38,445,149
| New | +$2B | 0.64% | 30 |
|
Other funds holding GILD
VCM
VPM
Wellington Management Group's GILD Position: Q1 2026 in Review
Wellington Management Group reduced its Gilead Sciences (GILD) stake by 15% in Q1 2026, selling an estimated $332M and leaving 13,537,991 shares worth $1.89B. The position accounts for 0.35% of the portfolio, ranked #62.
Wellington Management Group first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.16B in Q2 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Wellington Management Group held 13,537,991 shares of Gilead Sciences worth $1.89B as of Q1 2026.
- Wellington Management Group sold 2,369,313 Gilead Sciences shares in Q1 2026, an estimated $332M.
- Gilead Sciences made up 0.35% of Wellington Management Group's portfolio in Q1 2026, its #62 holding.
- Wellington Management Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Wellington Management Group's Gilead Sciences position peaked at $4.16B in Q2 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.